FILTER CONTENT

Filters
Company Names

Research

  • 7investing logo next to the Avita Medical logo.
    By Published On: February 17, 2025

    AVITA Medical: 2025 Will Be an “Inflection Point Year”

    AVITA Medical is continuing to show signs of progress. Its recently-reported fourth quarter [...]

  • By Published On: October 30, 2024

    Supermicro’s Accountant Resigns; Downgrading to “Hold”

  • By Published On: October 21, 2024

    October 2024 Conviction Rating Review

  • By Published On: September 19, 2024

    September 2024 Conviction Rating Review

  • By Published On: August 19, 2024

    August 2024 Conviction Rating Review

  • 7investing logo next to the CME Group logo.
    By Published On: August 2, 2024

    CME Group Gets a New Competitor; Shares are Inexpensive

  • 7investing logo next to the PubMatic logo.
    By Published On: June 27, 2024

    PubMatic is Turning the Corner; Upgrading to Strong Buy

  • By Published On: December 18, 2023

    7investing’s 2023 Year in Review: An Updated Look at All of Our Stock Picks

  • 7investing logo next to the Illumina logo.
    By Published On: September 13, 2023

    Illumina: New Leadership and a New Strategy; Changing our Conviction to “Hold”

  • 7investing logo next to the Guardant Health logo.
    By Published On: August 2, 2023

    Guardant and Illumina are Burying the Hatchet and Extending Their Partnership

  • By Published On: July 13, 2023

    Is Grail Good or Bad for Illumina?

  • By Published On: July 12, 2023

    Will SoFi Actually Become a Top 10 US Bank?

  • 7investing logo next to the PubMatic logo.
    By Published On: April 20, 2023

    PubMatic Keeps Winning Market Share

  • 7investing logo next to the Illumina logo.
    By Published On: April 11, 2023

    Despite the Drama, Illumina Celebrates 25 Years

  • Stock market charts with green arrow going up and red arrow going down
    By Published On: January 30, 2023

    SoFi’s Latest Monster Quarter Could Mark an Inflection Point

  • By Published On: December 19, 2022

    7investing’s 2022 Year in Review: An Updated Look at All of Our Stock Picks